Congressional Research Service Issues Insight White Paper on Class-Wide Scheduling of Fentanyl-Related Substances
December 04, 2024
December 04, 2024
WASHINGTON, Dec. 4 (TNSrep) -- The Congressional Research Service issued the following Insight white paper (No. IN12468) on Dec. 3, 2024, by Lisa N. Sacco, illicit drugs and crime policy analyst.
Here are excerpts:
* * *
Class-Wide Scheduling of Fentanyl-Related Substances (FRS)
Fentanyl is a synthetic opioid that has recognized medical uses in pain management; it is a Schedule II controlled substance under the federal Controlled Substances Act . . .
Here are excerpts:
* * *
Class-Wide Scheduling of Fentanyl-Related Substances (FRS)
Fentanyl is a synthetic opioid that has recognized medical uses in pain management; it is a Schedule II controlled substance under the federal Controlled Substances Act . . .